Evaluación del uso racional de gastroprotectores en el área de hospitalización del Hospital Geriátrico Dr. Bolivar Arguello, Riobamba

Abstract

The purpose of the study was to evaluate the rational use of gastroprotectors in patients from the hospitalization area of the Hospital Geriátrico Dr. Bolívar Arguello de Riobamba, of the year 2019, this was carried out through a descriptive, non-experimental, and retrospective research so that a total of 529 medical records were reviewed and criteria were applied of inclusion to establish a sample of 170 records belonging to older adults whose pharmacological treatment included gastroprotectors. The data was classified and tabulated in an Excel program 2002 version, to obtain charts and graphs that could be interpreted and discussed based on existing evidence. Most geriatric patients belonged to the females (62.4%), the gastroprotector prescribed with the highest incidence was omeprazole (92.42%) and the prevalent pathologies were hypertension (40.6%), pneumonia (25.3%), COPD (21.8%), urinary infections (20.6%), Diabetes Mellitus (11.2%), gastric diseases (10.6%) and diarrhea and gastroenteritis of presumed infectious origin (8.8%). PRMs were identified and evaluated so that moderate interactions were found (51.6%), mild (36.6%), and severe (11.8%). The multidisciplinary health team was trained on the rational use of gastroprotectors in geriatric patients, through digital media, where 20 health professionals related to the hospitalization area participated also the Director of the Health Unit. It was concluded that there was no rational use of gastroprotectors in older adults because 61.2% did not use them properly and are prone to adverse effects or problems related to medications specific to their age, that is why the work of the health team is important to promote and encourage rational use of medications.